folate-fluorescein conjugate
Small moleculeexperimentalImaging agent
Clinical trial activity
9 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00329368)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ec17
- ec17
- ec-17
- ec-17
- ec-17
- ec17 (folate-fitc)
- ec17 (folate-fitc)
- ec90
- ec90
- folate-fitc
- folate-fitc
- folate-fluorescein conjugate
- folate-fluorescein conjugate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02653612 | Phase 1 | Jan 1, 2016 | Department of Veteran Affairs, University of Pennsylvania |
| NCT01994369 | Phase 1 | May 1, 2014 | University of Pennsylvania |
| NCT02000778 | Phase 1 | Nov 1, 2013 | University of Pennsylvania |
| NCT01996072 | Phase 1 | Nov 1, 2013 | University of Pennsylvania |
| NCT01778933 | Early Phase 1 (Phase 1) | May 1, 2013 | University of Pennsylvania |
| NCT01778920 | Phase 1 | Apr 1, 2012 | Department of Veteran Affairs, University of Pennsylvania |
| NCT01511055 | Phase 2 | Jan 1, 2012 | Mayo Clinic |
| NCT00485563 | Phase 2 | Jun 1, 2007 | Endocyte |
| NCT00329368 | Phase 1 | Sep 1, 2005 | Endocyte |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 6 | 5 | 1 | 2012 |
| Department of Veteran Affairs | Government | 2 | 1 | 1 | 2012 |
| Endocyte | For profit | 2 | 2 | 2 | 2005 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2012 |
4 organizations
Page 1 / 1